These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8541872)

  • 1. Norrie disease and MAO genes: nearest neighbors.
    Chen ZY; Denney RM; Breakefield XO
    Hum Mol Genet; 1995; 4 Spec No():1729-37. PubMed ID: 8541872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Norrie disease gene maps to a 150 kb region on chromosome Xp11.3.
    Sims KB; Lebo RV; Benson G; Shalish C; Schuback D; Chen ZY; Bruns G; Craig IW; Golbus MS; Breakefield XO
    Hum Mol Genet; 1992 May; 1(2):83-9. PubMed ID: 1301161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, biochemical, and neuropsychiatric evaluation of a patient with a contiguous gene syndrome due to a microdeletion Xp11.3 including the Norrie disease locus and monoamine oxidase (MAOA and MAOB) genes.
    Collins FA; Murphy DL; Reiss AL; Sims KB; Lewis JG; Freund L; Karoum F; Zhu D; Maumenee IH; Antonarakis SE
    Am J Med Genet; 1992 Jan; 42(1):127-34. PubMed ID: 1308352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel contiguous deletion involving NDP, MAOB and EFHC2 gene in a patient with familial Norrie disease: bilateral blindness and leucocoria without other deficits.
    Jia B; Huang L; Chen Y; Liu S; Chen C; Xiong K; Song L; Zhou Y; Yang X; Zhong M
    J Genet; 2017 Dec; 96(6):1015-1020. PubMed ID: 29321361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence analysis and transcript identification within 1.5 MB of DNA deleted together with the NDP and MAO genes in atypical Norrie disease patients presenting with a profound phenotype.
    Suárez-Merino B; Bye J; McDowall J; Ross M; Craig IW
    Hum Mutat; 2001 Jun; 17(6):523. PubMed ID: 11385715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of biochemical and genetic findings in the diagnosis of atypical Norrie disease.
    Rodríguez-Muñoz A; García-García G; Menor F; Millán JM; Tomás-Vila M; Jaijo T
    Clin Chem Lab Med; 2018 Jan; 56(2):229-235. PubMed ID: 28742514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contiguous deletion of the NDP, MAOA, MAOB, and EFHC2 genes in a patient with Norrie disease, severe psychomotor retardation and myoclonic epilepsy.
    Rodriguez-Revenga L; Madrigal I; Alkhalidi LS; Armengol L; González E; Badenas C; Estivill X; Milà M
    Am J Med Genet A; 2007 May; 143A(9):916-20. PubMed ID: 17431911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a YAC containing part or all of the Norrie disease locus.
    Chen ZY; Sims KB; Coleman M; Donnai D; Monaco A; Breakefield XO; Davies KE; Craig IW
    Hum Mol Genet; 1992 Jun; 1(3):161-4. PubMed ID: 1303171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma amine oxidase activities in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase.
    Murphy DL; Sims KB; Karoum F; Garrick NA; de la Chapelle A; Sankila EM; Norio R; Breakefield XO
    J Neural Transm Gen Sect; 1991; 83(1-2):1-12. PubMed ID: 2018626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bidirectional YAC walk from the Norrie disease (NDP) locus.
    Black GC; Coleman MP; Chen ZY; Nemeth AH; Davies KE; Craig IW
    Genomics; 1995 Feb; 25(3):644-9. PubMed ID: 7759098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked amine and amine metabolite changes in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase.
    Murphy DL; Sims KB; Karoum F; de la Chapelle A; Norio R; Sankila EM; Breakefield XO
    J Neurochem; 1990 Jan; 54(1):242-7. PubMed ID: 2293615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and mapping of the mouse NDP (Norrie disease) locus (Ndp).
    Battinelli EM; Boyd Y; Craig IW; Breakefield XO; Chen ZY
    Mamm Genome; 1996 Feb; 7(2):93-7. PubMed ID: 8835523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of a candidate gene for Norrie disease by positional cloning.
    Berger W; Meindl A; van de Pol TJ; Cremers FP; Ropers HH; Döerner C; Monaco A; Bergen AA; Lebo R; Warburg M
    Nat Genet; 1992 Jun; 1(3):199-203. PubMed ID: 1303235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine oxidase deficiency in males with an X chromosome deletion.
    Sims KB; de la Chapelle A; Norio R; Sankila EM; Hsu YP; Rinehart WB; Corey TJ; Ozelius L; Powell JF; Bruns G
    Neuron; 1989 Jan; 2(1):1069-76. PubMed ID: 2483108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of MAOA and MAOB in a male patient causes severe developmental delay, intermittent hypotonia and stereotypical hand movements.
    Whibley A; Urquhart J; Dore J; Willatt L; Parkin G; Gaunt L; Black G; Donnai D; Raymond FL
    Eur J Hum Genet; 2010 Oct; 18(10):1095-9. PubMed ID: 20485326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norrie disease gene is distinct from the monoamine oxidase genes.
    Sims KB; Ozelius L; Corey T; Rinehart WB; Liberfarb R; Haines J; Chen WJ; Norio R; Sankila E; de la Chapelle A
    Am J Hum Genet; 1989 Sep; 45(3):424-34. PubMed ID: 2773935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screen for MAOA mutations in target human groups.
    Schuback DE; Mulligan EL; Sims KB; Tivol EA; Greenberg BD; Chang SF; Yang SL; Mau YC; Shen CY; Ho MS; Yang NH; Butler MG; Fink S; Schwartz CE; Berlin F; Breakefield XO; Murphy DL; Hsu YP
    Am J Med Genet; 1999 Feb; 88(1):25-8. PubMed ID: 10050962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical reinvestigation and linkage analysis in the family with Episkopi blindness (Norrie disease).
    Wolff G; Mayerová A; Wienker TF; Atalianis P; Ioannou P; Warburg M
    J Med Genet; 1992 Nov; 29(11):816-9. PubMed ID: 1453434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human monoamine oxidase gene (MAOA): chromosome position (Xp21-p11) and DNA polymorphism.
    Ozelius L; Hsu YP; Bruns G; Powell JF; Chen S; Weyler W; Utterback M; Zucker D; Haines J; Trofatter JA
    Genomics; 1988 Jul; 3(1):53-8. PubMed ID: 2906043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are MAO-A deficiency states in the general population and in putative high-risk populations highly uncommon?
    Murphy DL; Sims K; Eisenhofer G; Greenberg BD; George T; Berlin F; Zametkin A; Ernst M; Breakefield XO
    J Neural Transm Suppl; 1998; 52():29-38. PubMed ID: 9564605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.